BR9710568A - Composi- o farmac-utica contendo um antagonista 5Hht2c e um antagonista d2 - Google Patents

Composi- o farmac-utica contendo um antagonista 5Hht2c e um antagonista d2

Info

Publication number
BR9710568A
BR9710568A BR9710568A BR9710568A BR9710568A BR 9710568 A BR9710568 A BR 9710568A BR 9710568 A BR9710568 A BR 9710568A BR 9710568 A BR9710568 A BR 9710568A BR 9710568 A BR9710568 A BR 9710568A
Authority
BR
Brazil
Prior art keywords
antagonist
5hht2c
pharmaceutical composition
composition containing
pharmaceutical
Prior art date
Application number
BR9710568A
Other languages
English (en)
Inventor
Thomas Paul Blackburn
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of BR9710568A publication Critical patent/BR9710568A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BR9710568A 1996-07-26 1997-07-22 Composi- o farmac-utica contendo um antagonista 5Hht2c e um antagonista d2 BR9710568A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9615767.2A GB9615767D0 (en) 1996-07-26 1996-07-26 Novel treatment
PCT/EP1997/004159 WO1998004289A2 (en) 1996-07-26 1997-07-22 Pharmaceutical composition containing a 5ht2c antagonist and a d2 antagonist

Publications (1)

Publication Number Publication Date
BR9710568A true BR9710568A (pt) 1999-08-17

Family

ID=10797573

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9710568A BR9710568A (pt) 1996-07-26 1997-07-22 Composi- o farmac-utica contendo um antagonista 5Hht2c e um antagonista d2

Country Status (19)

Country Link
EP (1) EP0936924A2 (pt)
JP (1) JP2000516924A (pt)
KR (1) KR20000029564A (pt)
CN (1) CN1230894A (pt)
AR (1) AR008083A1 (pt)
AU (1) AU725817B2 (pt)
BR (1) BR9710568A (pt)
CA (1) CA2261813A1 (pt)
CO (1) CO5031292A1 (pt)
CZ (1) CZ23799A3 (pt)
GB (1) GB9615767D0 (pt)
HU (1) HUP9903619A3 (pt)
IL (1) IL128219A0 (pt)
NO (1) NO990322L (pt)
NZ (1) NZ333813A (pt)
PL (1) PL331426A1 (pt)
TR (1) TR199900140T2 (pt)
WO (1) WO1998004289A2 (pt)
ZA (1) ZA976593B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9612883D0 (en) * 1996-06-20 1996-08-21 Smithkline Beecham Plc Novel compounds
AU757870B2 (en) * 1998-11-23 2003-03-06 Sepracor, Inc. Pharmaceutical compositions containing olanzapine-N-oxide
EP1133299A1 (en) 1998-11-23 2001-09-19 Sepracor Inc. 2-hydroxymethylolanzapine compositions and methods
DE69923081T2 (de) 1998-11-23 2005-12-08 Sepracor Inc., Marlborough Desmethylolanzapine enthaltende zusammensetzungen und verfahren
CA2366838A1 (en) * 1999-03-18 2000-09-21 Gina Guadagno A method of treating bulimia nervosa and related eating disorders by administration of atypical antipsychotic medications
CA2363784A1 (en) * 1999-05-19 2000-11-30 Astrazeneca Ab Method of treatment
WO2005013969A1 (en) * 2003-07-15 2005-02-17 Janssen Pharmaceutica N.V. Antipsychotic agent with socializing properties

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9500998D0 (sv) * 1995-03-19 1995-03-19 Haakan Wilhelm Wikstroem New sulfone ester analogues of iso-clozapine and related structures: atypical neuroleptics

Also Published As

Publication number Publication date
GB9615767D0 (en) 1996-09-04
HUP9903619A3 (en) 2001-03-28
EP0936924A2 (en) 1999-08-25
JP2000516924A (ja) 2000-12-19
HUP9903619A2 (hu) 2000-10-28
PL331426A1 (en) 1999-07-19
AU725817B2 (en) 2000-10-19
WO1998004289A3 (en) 1998-03-19
NO990322L (no) 1999-03-24
AU4297297A (en) 1998-02-20
AR008083A1 (es) 1999-12-09
CO5031292A1 (es) 2001-04-27
CA2261813A1 (en) 1998-02-05
KR20000029564A (ko) 2000-05-25
NO990322D0 (no) 1999-01-25
CZ23799A3 (cs) 1999-06-16
WO1998004289A2 (en) 1998-02-05
ZA976593B (en) 1999-01-25
TR199900140T2 (xx) 1999-03-22
NZ333813A (en) 2000-07-28
IL128219A0 (en) 1999-11-30
CN1230894A (zh) 1999-10-06

Similar Documents

Publication Publication Date Title
EE04440B1 (et) Kaparetseptori opioidpeptiidid ja farmatseutilinekompositsioon
DE69726015D1 (de) Pharmazeutische zusammensetzung enthaltend koenzym q-10
NO20004345D0 (no) Farmasøytisk sammensetning
DE69807420D1 (de) Pharmazeutische aerosolzusammensetzung
BR9707812A (pt) Composto composto farmacêutica e uso do composto
EE9900545A (et) Farmatseutiline kompositsioon
BR9509688A (pt) Composto e composição farmacêutica
DE59801987D1 (de) Pharmazeutische zusammensetzung enthaltend peptichemio
BR9507768A (pt) Composição farmacêutica
FI973229L (fi) Uusi farmaseuttinen koostumus
ID29294A (id) Komposisi farmasi
LV11727A (lv) Farmaceitiska kompozicija
ID18698A (id) Komposisi farmasi
BR9710568A (pt) Composi- o farmac-utica contendo um antagonista 5Hht2c e um antagonista d2
ID25857A (id) Komposisi farmasi
FI973280L (fi) Farmaseuttinen koostumus
ITMI962628A0 (it) Composizione farmaceutica
BR9605777A (pt) Composição farmacêutica
ID23531A (id) Komposisi farmasi
BR9605131A (pt) Composição farmacêutica
BR9505130A (pt) Composto e composiçao farmacêutica
IT1272935B (it) Composizione farmaceutica contenente n-acetil-cisteina
BR1101151A (pt) Compostos e composição farmacêutica
BR1100391A (pt) Composto e composição farmacêutica
SE9703737D0 (sv) Pharmaceutical composition and use

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]